Yang XX - Search Results

1

Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.

Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, Duan W, Yang HY, Zhu YZ, Zhou SF. Chen X, et al. Among authors: yang hy, yang xx. Int Immunopharmacol. 2006 Mar;6(3):499-508. doi: 10.1016/j.intimp.2005.08.026. Epub 2005 Sep 15. Int Immunopharmacol. 2006. PMID: 16428086 Clinical Trial.

2

Monitoring drug-protein interaction.

Yang XX, Hu ZP, Chan SY, Zhou SF. Yang XX, et al. Clin Chim Acta. 2006 Mar;365(1-2):9-29. doi: 10.1016/j.cca.2005.08.021. Epub 2005 Sep 30. Clin Chim Acta. 2006. PMID: 16199025 Review.

3

Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.

Yang XX, Hu ZP, Chan SY, Duan W, Ho PC, Boelsterli UA, Ng KY, Chan E, Bian JS, Chen YZ, Huang M, Zhou SF. Yang XX, et al. Curr Drug Metab. 2006 May;7(4):431-55. doi: 10.2174/138920006776873517. Curr Drug Metab. 2006. PMID: 16724931

4

St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.

Hu Z, Yang X, Ho PC, Chan E, Chan SY, Xu C, Li X, Zhu YZ, Duan W, Chen X, Huang M, Yang H, Zhou S. Hu Z, et al. Pharm Res. 2005 Jun;22(6):902-14. doi: 10.1007/s11095-005-4585-0. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948034

5

Small interfering RNA-mediated silencing of cytochrome P450 3A4 gene.

Chen J, Yang XX, Huang M, Hu ZP, He M, Duan W, Chan E, Sheu FS, Chen X, Zhou SF. Chen J, et al. Among authors: yang xx. Drug Metab Dispos. 2006 Sep;34(9):1650-7. doi: 10.1124/dmd.106.009837. Epub 2006 Jun 7. Drug Metab Dispos. 2006. PMID: 16760227

6

A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.

Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF. Yang XX, et al. J Pharmacol Exp Ther. 2006 Oct;319(1):82-104. doi: 10.1124/jpet.106.103606. Epub 2006 Jun 30. J Pharmacol Exp Ther. 2006. PMID: 16815871

7

St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.

Hu ZP, Yang XX, Chan SY, Xu AL, Duan W, Zhu YZ, Sheu FS, Boelsterli UA, Chan E, Zhang Q, Wang JC, Ee PL, Koh HL, Huang M, Zhou SF. Hu ZP, et al. Among authors: yang xx. Toxicol Appl Pharmacol. 2006 Oct 15;216(2):225-37. doi: 10.1016/j.taap.2006.05.020. Epub 2006 Jul 21. Toxicol Appl Pharmacol. 2006. PMID: 17015070

8

Drug-herb interactions: eliminating toxicity with hard drug design.

Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF. Yang XX, et al. Curr Pharm Des. 2006;12(35):4649-64. doi: 10.2174/138161206779010440. Curr Pharm Des. 2006. PMID: 17168768 Review.

9

Herb-drug interactions: a literature review.

Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S. Hu Z, et al. Drugs. 2005;65(9):1239-82. doi: 10.2165/00003495-200565090-00005. Drugs. 2005. PMID: 15916450 Review.

10

Novel agents that potentially inhibit irinotecan-induced diarrhea.

Yang X, Hu Z, Chan SY, Chan E, Goh BC, Duan W, Zhou S. Yang X, et al. Curr Med Chem. 2005;12(11):1343-58. doi: 10.2174/0929867054020972. Curr Med Chem. 2005. PMID: 15975002 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

511 results

Search Page